MEDANTA

a healthcare facilities company, reported strong Q4FY25...

a healthcare facilities company, reported strong Q4FY25 and FY25 results, driven by increased patient volumes. In Q4FY25, consolidated total income grew by 14.1% YoY to Rs 9,542 million. EBITDA rose by 19.8% to Rs 2,476 million, with margins improving to 26.0% from 24.7% in Q4FY24. Reported PAT stood at Rs 1,014 million, with margins of 10.6%, impacted by a one-time exceptional expense of Rs 499 million due to the merger of MHPL with GHL. Adjusted PAT was Rs 1,387 million, showing 8.9% YoY growth and a margin of 14.5%. For FY25, the company recorded consolidated total income of Rs 37,714 million, a 12.6% YoY increase. EBITDA grew 9.4% to Rs 9,562 million, with margins at 25.4% versus 26.1% in FY24. PAT was Rs 4,813 million with a margin of 12.8%, while adjusted PAT stood at Rs 5,186 million, reflecting 8.5% YoY growth and 13.8% margin. The board recommended a final dividend of Rs 0.50 per share (25% of face value). Group CEO and Director Pankaj Sahni called FY25 a landmark year, highlighting the 15-year milestone of Medanta Gurugram and its continued recognition as India’s Best Private Hospital. He emphasized the company’s focus on clinical excellence and investment in technological advancement. He also outlined future growth, including the upcoming 550-bed Noida facility set to open in Q2 FY26 and three new greenfield projects in Mumbai, Pitampura, and Guwahati, expected to become operational in 3–4 years.